sōna

COCCIDIOIDES ANTIBODY

LATERAL FLOW ASSAY


It's About

TIME

Coccidioidomycosis (Valley Fever) is difficult to diagnosis due to lack of awareness and symptoms imitating many other respiratory infections.

Valley Fever is said to cause nearly 30% of all community acquired pneumonia (CAP) cases, but only about 15,000 cases are reported each year in the US.1 IMMY’s simple, rapid LFA allows for better care and stewardship for patients.

FDA: Serum
Results in just

30 MINUTES

Reduce Sendouts
Reduce

SEND-OUT TESTING

Run On All Shifts
Run on

ALL SHIFTS


Clinical Relevancy

SERUM Positive % Agreement Negative % Agreement PPV NPV
Competitor EIA 93% 99% 94% 99%
Competitor EIA + ID 92% 99% 94% 99%
1) Contreras DA, Li Q, Garner OB. Evaluation of Sona Lateral Flow Assay for the Rapid Detection of Coccidioides Immitis. Poster session presented at: American Society for Microbiology Microbe. 2019 June 20-24; San Francisco, CA.

When tested against a competitor’s EIA and ID results, the CTA LFA showed high diagnostic performance in 908 serum specimens.

The CTA LFA agreed with 93% of the competitor’s EIA positive test results, and 99% of their negative test results. When compared to both the competitor’s EIA and ID results, the CTA LFA agreed with 92% of their positive results and 99% of their negative results.